Active ingredientPyrimethamineCat. No. P-P240-001CAS 58-14-0Family · Pharmaceutical analytical standards
Pyrimethamine
An antiparasitic that blocks the enzyme dihydrofolate reductase, discovered in 1952 and in use since 1953: born to fight malaria, it is also used against toxoplasmosis, together with sulfadiazine, and it has been included in the WHO List of Essential Medicines. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?It was developed by Gertrude Elion, an American biochemist and pharmacologist who in 1988 received the Nobel Prize in Physiology or Medicine for discovering important principles of drug treatment.
Go to the active ingredient →Active ingredientPyrimethamineCat. No. P-P240-001CAS 58-14-0
Pharmacopoeial impurityPyrimethamine EP Impurity ACat. No. P-P240-002CAS 55474-40-3
Pharmacopoeial impurityPyrimethamine EP Impurity DCat. No. P-P240-003CAS 55474-41-4
Isotopically labelledPyrimethamine-d3Cat. No. P-P240-004CAS 1189936-99-9
Isotopically labelledPyrimethamine-d5Cat. No. P-P240-005
ImpurityPyrimethamine impurity b (ep impurity)Cat. No. P-P240-006CAS 3275-44-3
ImpurityPyrimethamine Impurity 1Cat. No. P-P240-007
ImpurityPyrimethamine N1-OxideCat. No. P-P240-008
ImpurityPyrimethamine N3-OxideCat. No. P-P240-009CAS 91284-15-0No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Reference substancePyrimethamine CRSEDQM code P4200000Family PyrimethamineImpurityPyrimethamine impurity B CRSEDQM code Y0002066Family PyrimethamineNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.